Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Feb 24, 2021•over 4 years ago
Amount Raised
$105 Million
Round Type
series c
Description
Truvian Sciences ("Truvian") today announced the close of more than $105 million in an oversubscribed Series C financing round led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures. The funds will advance development of Truvian's automated benchtop blood testing system, paving the way to submit the device for U.S. Food and Drug Administration (FDA) clearance, and enabling the company to scale its team in preparation for broad commercialization. Inclusive of the Series C, Truvian has raised more than $150 million in funding to date.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech